16alpha-Hydroxyprednisolone

CAS No. 13951-70-7

16alpha-Hydroxyprednisolone( —— )

Catalog No. M21638 CAS No. 13951-70-7

16alpha-Hydroxyprednisolone is a stereoselective metabolite of the 22(R) epimer of the glucocorticoid budesonide.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote In Stock
200MG 29 In Stock
500MG 45 In Stock
1G 60 In Stock

Biological Information

  • Product Name
    16alpha-Hydroxyprednisolone
  • Note
    Research use only, not for human use.
  • Brief Description
    16alpha-Hydroxyprednisolone is a stereoselective metabolite of the 22(R) epimer of the glucocorticoid budesonide.
  • Description
    16alpha-Hydroxyprednisolone is a stereoselective metabolite of the 22(R) epimer of the glucocorticoid budesonide.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    13951-70-7
  • Formula Weight
    376.44
  • Molecular Formula
    C21H28O6
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (265.65 mM)
  • SMILES
    [H][C@@]12C[C@@H](O)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C
  • Chemical Name
    (8S9S10R11S13S14S16R17S)-111617-Trihydroxy-17-(2-hydroxyacetyl)-1013-dimethyl-7891112141516-octahydro-6H-cyclopenta[a]phenanthren-3-one

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.J?nsson G Astr?m A Andersson P. Budesonide is metabolized by cytochrome P450 3A (CYP3A) enzymes in human liver[J]. drug metabolism & disposition the biological fate of chemicals 1995 23(1):137.
molnova catalog
related products
  • Procumbenoside E

    The herbs of Sinopodophyllum hexandrum.

  • Atracurium besylate

    Atracurium besylate is a non-depolarizing neuromuscular blocking agent with short duration of action. Its lack of significant cardiovascular effects and its lack of dependence on good kidney function for elimination provide clinical advantage over alternate non-depolarizing neuromuscular blocking agents.

  • 2-Aminoisobutyric ac...

    Aminoisobutyric acid is a nonprotein amino acid (is an end product of pyrimidine metabolism) excreted in the urine of about 5% of healthy individuals and high excretion is an autosomal recessive phenotype.